Edgewise Therapeutics, Inc.
EWTX
Jodie situation report
Edgewise Therapeutics, Inc.'s move is being confirmed by its market group.
EWTX accounts for 9.5% of the group's measured movement across 5.6 effective names. raw member direction is mixed; 7 of 12 session-normalized paths align to the upside. Capital-flow agreement is 16%, so confirmation is not yet clean. No verified headline preceded the measured group move.
Is this move genuinely shared?
EWTX was the first measured mover. EWTX crossed its material path threshold at 15:50 ET. AXSM, ALMS, GPCR followed.
10 of 16 members in Clinical Biopharmaceuticals are active. 0 of 8 disclosed connections are confirming.
- At least 11 of 16 durable members become active together.
- Capital-flow agreement rises above 55%.
- A filing-linked outsider such as NBIX begins moving with the group.
Invalidation: The live read weakens if participation falls to 5 of 16 members or fewer.
Who this business touches
The relationships behind EWTX
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
CYTKCytokinetics, IncorporatedcompetitorMay 7, 2026 ▾
“In the field of emerging treatments for HCM, competitors include Bristol-Myers Squibb (BMS), Cytokinetics, Imbria Pharmaceuticals, Lexicon Pharmaceuticals, and Celltrion, and Braveheart Bio.”
CYTKCytokinetics, IncorporatedsupplierFeb 26, 2026 ▾
“The effects of EDG-7500 on cardiac function overlap with some of the desirable attributes of the cardiac myosin inhibitors (CMIs) such as BMS’s CAMZYOS® (mavacamten) and Cytokinetics’ MYQORZO (aficamten).”
Depended on by
CYTKCytokinetics, IncorporatedcompetitorFeb 26, 2026 ▾
“In addition to Camzyos®, Edgewise Therapeutics, Lexicon, Tenaya and Braveheart Bio (Hengrui) are conducting clinical trials and could commercialize a drug that would compete with MYQORZO if successful.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 7 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
EWTX is currently a Participant in the organic co-movement group Clinical Biopharmaceuticals. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.